Allergan announces positive topline Phase 3 results for presbyopia therapeutic
by: David Hutton, OT Staff Reports According to the company, the VIRGO trial evaluated the safety and efficacy of the investigational twice-daily administration of pilocarpine HCl ophthalmic solution 1.25% in adults…